Global Xerosis Treatment Market By Signs and Symptoms (Tightness, Roughness, Itching, Others), Medication (Corticosteroids, Immuno-Modulators, Topical Moisturizers, Others), Route of Administration (Oral, Topical, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Xerosis Treatment Market

Global xerosis treatment market is rising gradually with the substantial CAGR of 6.0% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of skin dryness may drive the market in the forecast period.

Market Definition: Global Xerosis Treatment Market

Xerosis or “dry skin” is caused by lack of moisture in the skin. This lack of moisture in skin can be caused by ageing or by underlying diseases such as diabetes. Xerosis generally occurs on the lower legs and can also occur on trunk, forearms and hands. It may appear on face too. Xerosis is also called xeroderma or xerosis cutis.

The prevalence of xerosis or xeroderma is approximately 1 case in 100,000 people. The occurrence of this condition in males and females is equal. The prevalence is more common in areas including North Africa and Middle East.

Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-xerosis-treatment-market

Market Drivers

Rising awareness about xerosis and its treatments will increase the market in the forecast period
Influence of healthy and quality lifestyle and fashion industry are key factors that propel the market growth
Increasing climatic changes and pollution are major causes of xerosis; which boosts the growth of the market
Growing geriatric population will drive the market growth in the future

Market Restraints

Presence of ineffective or fake products hampers the market growth
Pressure of cost reduction of many potential products due to cut throat competition hinder the growth of the market
Large number of low quality players which have fragmented the market may restraint the market growth

Segmentation: Global Xerosis Treatment Market

By Signs and Symptoms

Tightness
Roughness
Itching
Others

By Medication

Corticosteroids
Immuno-Modulators
Topical Moisturizers
Others

By Route of Administration

Oral
Topical
Others

By End Users

Hospitals
Homecare
Specialty Clinics
Others

By Distribution Channels

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others

By Geography

North America
U.S.
Canada
Mexico
South America
Brazil
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa

Key Development in the Market:

In April 2019, HRA Pharma announced an acquisition of Mederma, a skin care treatment product of Merz Pharma. Mederma is used for the treatment of scars, stretch marks and dry skin which is the most common symptom of xerosis. This acquisition will provide the rights to market and commercialize of the product worldwide which will strengthen the business portfolio of the company

Competitive Analysis:

Global xerosis treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of xerosis treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in global xerosis treatment market are HRA Pharma, Merz Pharma, PuraCap Pharmaceutical LLC, Prince Care Pharma Pvt Ltd., Nemus Pharma, UAS Pharmaceuticals, Ovelle, CHEIRON PHARMA, Ceragenix Pharmaceuticals, Taro Pharmaceutical Industries Ltd., Galderma Laboratories, L.P., Unilever, Hempz, New Avon Company, Johnson & Johnson Services, Inc., Croda International Plc, Estée Lauder Inc, Dow, Pfizer Inc., Amgen Inc., Bayer AG, Mylan N.V. among others.